Literature DB >> 11902306

Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.

F S Huang1, T Zwerdling, L E Stern, E T Ballard, B W Warner.   

Abstract

Numerous children have been treated successfully for cancer and are surviving into adulthood. As this population has aged, an increasing number of secondary malignancies has emerged. Renal cell carcinoma (RCC) is a rare tumor in childhood and has not been documented previously to occur after treatment of acute promyelocytic leukemia (APL). This report describes the clinical course of APL treated in a child in whom RCC subsequently developed during adolescence approximately 5 years after therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11902306     DOI: 10.1097/00043426-200112000-00011

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide.

Authors:  Alireza Eghtedar; Ildefonso Rodriguez; Hagop Kantarjian; Susan O'Brien; Naval Daver; Guillermo Garcia-Manero; Alessandra Ferrajoli; Tapan Kadia; Sherry Pierce; Jorge Cortes; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2014-11-03

Review 2.  Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood.

Authors:  Julie M Fleitz; Sandra L Wootton-Gorges; Josephine Wyatt-Ashmead; Loris McGavran; Martin Koyle; Daniel C West; Eric A Kurzrock; Kenneth W Martin; Lorrie F Odom
Journal:  Pediatr Radiol       Date:  2003-05-14

3.  Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Authors:  Janice P Dutcher; Peter H Wiernik; Leticia Varella; Rangaswamy Chintapatla
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.